CYTK Q1 2018 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+26.8% YoY

Gross Profit

-$17M-320.2% margin

Operating Income

-$26M-496.0% margin

Net Income

-$30M-574.8% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

+29366.7%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$280M

Total Liabilities

$180M

Stockholders' Equity

$100M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+26.8%
Gross Profit	-$17M	-$15M	-11.4%
Operating Income	-$26M	-$23M	-12.4%
Net Income	-$30M	-$26M	-17.1%